The efficacy of once-daily applications of 0.05% diflorasone diacetate in a cream or ointment formulation was evaluated in a 3-week study of 301 patients with eczematous dermatoses. The lesions were classified by severity and included those of an acute, sub-acute or chronic nature. Clinical evaluations were based on overall lesion improvement and improvement in specific signs and symptoms. Over 80% of patients reported the therapy to be good or excellent. Sixteen patients reported side-effects consisting largely of transient burning and stinging.
Get full access to this article
View all access options for this article.
References
1.
BluefarbS MHowardF MLeibsohnESchlagelC A (1976) Diflorasone diacetate: Vasoconstrictor activity and clinical efficacy of a new topical corticosteroid. Journal of International Medical Research, 4, 454.
2.
CahnM MHallJ HKirschenbaumM BLeibsohnEPengV TRothH LSavinR CSchlagelC A (1977) Comparative topical efficacy of once-daily diflorasone diacetate and t.i.d. betamethasone valerate ointment applications. Current Therapeutic Research22, 297.
3.
LawlessJ FStubbsS S (1978) Comparative efficacy of once-a-day diflorasone diacetate and t.i.d. hydrocortisone in treating eczematous dermatitis. Current Therapeutic Research23, 159.
4.
TurfJ SDanielsonDWoltersomJ W (1979) Effects of polyoxypropylene 15 stearyl ether and propylene glycol on percutaneous penetration rate of diflorasone diacetate. Journal of Pharmaceutical Sciences68, 275.
